Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment

Area of Science:

• Oncology
• Pathology
• Pulmonology

Background:

• Diffuse pleural mesothelioma (DPM) is a rare but aggressive cancer originating in the lung lining.
• Asbestos exposure is the primary known risk factor for DPM development.
• Recent molecular and clinical research has improved understanding and management of DPM.

Purpose of the Study:

• To provide a comprehensive review of current concepts and emerging trends in DPM.
• To cover key aspects including risk factors, pathobiology, histologic subtyping, and therapeutic strategies.
• To emphasize the importance of a multidisciplinary approach for managing DPM.

Main Methods:

• Literature review of recent advances in DPM research.
• Synthesis of information on molecular pathogenesis, epidemiology, and clinical management.
• Focus on current diagnostic criteria and therapeutic options.

Main Results:

• DPM pathogenesis is increasingly understood at a molecular level.
• Histologic subtyping impacts prognosis and treatment selection.
• Multidisciplinary care is crucial for optimal patient outcomes.

Conclusions:

• Advances in understanding DPM molecular biology are reshaping clinical practice.
• Accurate histologic subtyping and a multidisciplinary approach are essential for effective DPM management.
• Continued research is vital for improving outcomes in diffuse pleural mesothelioma.